Company Description
Isis Pharmaceuticals is trying to make sense out of antisense. The biotechnology company is developing drug therapies based on antisense...
Key Isis Pharmaceuticals Financials
| Company Type | Public - NASDAQ (GM): ISIS Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $69.6 |
| 2005 Employees | 258 |
More Isis Pharmaceuticals Financials (11 pages)
Latest Isis Pharmaceuticals Jobs jobs by Indeed
Competition
Competitive Landscape for Chemicals
Demand is driven by the health of the US economy because chemicals are used to make a wide variety of industrial and consumer products. The profitability of individual companies is closely tied to...
Read more about Isis Pharmaceuticals's competition across multiple industries
Top Isis Pharmaceuticals Competitors
Sponsored Links
The Business Directory
Isis Pharmaceuticals Executives
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman, President, and CEO | Stanley T. Crooke | Network | E-mail |
| COO, CFO, Secretary, and Director | B. Lynne Parshall | Network | E-mail |
| VP Informatics | John McNeil | Network | E-mail |
More Isis Pharmaceuticals Executives
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Isis Pharmaceuticals News
- Antimicrobial biaryl compounds [U.S. Patents] (15 Oct 2008 10:28:00 EDT)
- Oligoribonucleotides and ribonucleases for cleaving RNA [U.S. Patents] (15 Oct 2008 10:28:00 EDT)
- Oligoribonucleotides and ribonucleases for cleaving RNA [U.S. Patents] (15 Oct 2008 10:28:00 EDT)
Latest Isis Pharmaceuticals Video
-
Spotlight on Isis Pharma (2:47)
01/07/08 3:22ET - CNBC's Mike Huckman interviews Isis Pharmaceuticals CEO Stanley Crooke at the JPMorgan Healthcare Conference.
Sponsored Opportunity
